Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
D002170:Canada / Q000453:epidemiology; D004196:Disease Outbreaks / Q000517:prevention & control*; D006506:Hepatitis A / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology; D022362:Hepatitis A Vaccines; D006801:Humans; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage* / Q000276:immunology
D022362:Hepatitis A Vaccines; D014761:Viral Hepatitis Vaccines